<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Wed, 09 Jul 2008 13:38:01 BST</pubDate>


	<title>CiteULike: AlfonsoVicenteSuarezs Wu</title>
	<description>CiteULike: AlfonsoVicenteSuarezs Wu</description>


	<link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/author/Wu</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452955"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1318284"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452955">
    <title>Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1452955</link>
    <description>&lt;i&gt;Immunity, Vol. 12, No. 6. (June 2000), pp. 721-727.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Here we describe a family of GPI-anchored cell surface proteins that function as ligands for the mouse activating NKG2D receptor. These molecules are encoded by the retinoic acid early inducible (RAE-1) and H60 minor histocompatibility antigen genes on mouse chromosome 10 and show weak homology with MHC class I. Expression of the NKG2D ligands is low or absent on normal, adult tissues; however, they are constitutively expressed on some tumors and upregulated by retinoic acid. Ectopic expression of RAE-1 and H60 confers target susceptibility to NK cell attack. These studies identify a family of ligands for the activating NKG2D receptor on NK and T cells, which may play an important role in innate and adaptive immunity.</description>
    <dc:title>Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.</dc:title>

    <dc:creator>A Cerwenka</dc:creator>
    <dc:creator>AB Bakker</dc:creator>
    <dc:creator>T McClanahan</dc:creator>
    <dc:creator>J Wagner</dc:creator>
    <dc:creator>J Wu</dc:creator>
    <dc:creator>JH Phillips</dc:creator>
    <dc:creator>LL Lanier</dc:creator>
    <dc:source>Immunity, Vol. 12, No. 6. (June 2000), pp. 721-727.</dc:source>
    <dc:date>2007-07-12T20:32:30-00:00</dc:date>
    <prism:publicationYear>2000</prism:publicationYear>
    <prism:publicationName>Immunity</prism:publicationName>
    <prism:issn>1074-7613</prism:issn>
    <prism:volume>12</prism:volume>
    <prism:number>6</prism:number>
    <prism:startingPage>721</prism:startingPage>
    <prism:endingPage>727</prism:endingPage>
    <prism:category>ra</prism:category>
    <prism:category>rae-1</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1318284">
    <title>&#34;Alternatively activated&#34; dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1318284</link>
    <description>&lt;i&gt;J Immunol, Vol. 177, No. 9. (1 November 2006), pp. 5868-5877.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;In this study, we propagated myeloid dendritic cells (DC) from BALB/c (H2(d)) mouse bone marrow progenitors in IL-10 and TGF-beta, then stimulated the cells with LPS. These &#34;alternatively activated&#34; (AA) DC expressed lower TLR4 transcripts than LPS-stimulated control DC and were resistant to maturation. They expressed comparatively low levels of surface MHC class II, CD40, CD80, CD86, and programmed death-ligand 2 (B7-DC; CD273), whereas programmed death-ligand 1 (B7-H1; CD274) and inducible costimulatory ligand expression were unaffected. AADC secreted much higher levels of IL-10, but lower levels of IL-12p70 compared with activated control DC. Their poor allogeneic (C57BL/10; B10) T cell stimulatory activity and ability to induce alloantigen-specific, hyporesponsive T cell proliferation was not associated with enhanced T cell apoptosis. Increased IL-10 production was induced in the alloreactive T cell population, wherein CD4+Foxp3+ cells were expanded. The AADC-expanded allogeneic CD4+CD25+ T cells showed enhanced suppressive activity for T cell proliferative responses compared with freshly isolated T regulatory cells. In vivo migration of AADC to secondary lymphoid tissue was not impaired. A single infusion of BALB/c AADC to quiescent B10 recipients induced alloantigen-specific hyporesponsive T cell proliferation and prolonged subsequent heart graft survival. This effect was potentiated markedly by CTLA4-Ig, administered 1 day after the AADC. Transfer of CD4+ T cells from recipients of long-surviving grafts (&#62;100 days) that were infiltrated with CD4+Foxp3+ cells, prolonged the survival of donor-strain hearts in naive recipients. These data enhance insight into the regulatory properties of AADC and demonstrate their therapeutic potential in vascularized organ transplantation.</description>
    <dc:title>&#34;Alternatively activated&#34; dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.</dc:title>

    <dc:creator>YY Lan</dc:creator>
    <dc:creator>Z Wang</dc:creator>
    <dc:creator>G Raimondi</dc:creator>
    <dc:creator>W Wu</dc:creator>
    <dc:creator>BL Colvin</dc:creator>
    <dc:creator>A de Creus</dc:creator>
    <dc:creator>AW Thomson</dc:creator>
    <dc:source>J Immunol, Vol. 177, No. 9. (1 November 2006), pp. 5868-5877.</dc:source>
    <dc:date>2007-05-21T21:30:40-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>J Immunol</prism:publicationName>
    <prism:issn>0022-1767</prism:issn>
    <prism:volume>177</prism:volume>
    <prism:number>9</prism:number>
    <prism:startingPage>5868</prism:startingPage>
    <prism:endingPage>5877</prism:endingPage>
    <prism:category>tolerogenic-dcs</prism:category>
</item>



</rdf:RDF>

